QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2020_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 2,672,033
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 237,898
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,669,160
9 ResearchAndDevelopmentExpense 820,906
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 49,723
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,672,033
1 Liabilities 237,898
2 Expenses 2,490,066
3 Revenues 0
4 StockholdersEquity 2,434,135
5 NetIncome -2,440,343
6 ComprehensiveNetIncome -2,440,343
7 BaseVar 2,724,860
8 EconomicCapitalRatio 1.20

Edgar->Model Mapping

Feature Distribution

Change over Time